Hydralazine-associated adverse events: a report of two cases of hydralazine-induced ANCA vasculitis

Autor: Roman Zuckerman, Mayurkumar Patel, Eric J Costanzo, Harry Dounis, Rany Al Haj, Seyedehsara Seyedali, Arif Asif

Publikováno v: Brazilian Journal of Nephrology, Iss 0 (2018)

Abstract Hydralazine is a direct-acting vasodilator, which has been used in treatment for hypertension (HTN) since the 1950s. While it is well known to cause drug-induced lupus (DIL), recent reports are indicating the emergence of the drug-induced an

Externí odkaz: https://doaj.org/article/9f47a7ca80694cc2ae737ebc0e6fa1ce

Hydralazine-associated adverse events: a report of two cases of hydralazine-induced ANCA vasculitis

Autor: Seyedehsara Seyedali, Roman Zuckerman, Arif Asif, Rany Al Haj, Eric J. Costanzo, Mayurkumar Patel, Harry Dounis

Publikováno v: Brazilian Journal of Nephrology v.40 n.2 2018
Jornal Brasileiro de Nefrologia
Sociedade Brasileira de Nefrologia (SBN)
instacron:SBN
Brazilian Journal of Nephrology, Issue: ahead, Published: 07 MAY 2018
Brazilian Journal of Nephrology, Volume: 40, Issue: 2, Pages: 193-197, Published: 07 MAY 2018
Brazilian Journal of Nephrology, Iss 0 (2018)

Hydralazine is a direct-acting vasodilator, which has been used in treatment for hypertension (HTN) since the 1950s. While it is well known to cause drug-induced lupus (DIL), recent reports are indicating the emergence of the drug-induced anti-neutro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::273760bcc1afc7d06247609ff6dd9f3b
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002018000200193

Plasmaférese como tratamento de glomeruloesclerose segmentar focal (GESF) recorrente após transplante renal. Relato de caso e revisão da literatura

Autor: Moraes,Mara C., Roveri,Eduardo G., Oliveira,Lívia C., Rigatto,Sumara Z. P., Belangero,Vera M. S., Marques Jr,José Francisco C.

Publikováno v: Revista Brasileira de Hematologia e Hemoterapia v.29 n.2 2007
Revista brasileira de hematologia e hemoterapia
Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC)
instacron:ABHHTC

A glomerulosclerose segmentar focal (GESF) é uma doença renal caracterizada por síndrome nefrótica, com freqüente progressão para insuficiência renal terminal. Nesta fase, o transplante renal, tanto com doador cadáver como intervivos, aparece

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3056::de86bbc9eb852271a666fc8bc3b127ff
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842007000200020